Analysis of platelet function in patients with infection and sepsis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039370

Enrollment

100

Registered

2026-02-18

Start date

2025-02-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A41

Interventions

Group 1: Patients with sepsis or septic shock and SOFA score = 7 Blood samples will be collected at the following time points: Day 1 (day of study inclusion) Day 3 Day 7 At discharge Optional later ti

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Age >= 18 years -Written informed consent from the patient or their legal representative or authorized proxy - SOFA = 7

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding ECMO treatment prior to study inclusion Aplasia following chemotherapy or hematopoietic stem cell transplantation

Design outcomes

Primary

Measure	Time frame
Demographics (age, sex) Severity of illness (SIRS criteria, SOFA score, APACHE II score, ventilation parameters) Previous treatment outcomes, complications, and in-hospital mortality	—

Secondary

Measure	Time frame
infection parameters (virologic-, microbioloic-, immunologic- results) and laboratoric routine data	—

Countries

Germany

Contacts

Public ContactKarina Althaus

Institut für klinische und experimentelle Transfusionsmedizin

Karina.Althaus@med.uni-tuebingen.de+4970712981606

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026